Chemical AMPylomics targeting a novel host pathogen interaction
In 2009 protein AMPylation, the reversible post-translational adenylation of target proteins with adenosine monophosphate (AMP), was first revealed as a novel mechanism for pathogenic bacteria to target and disrupt interactions of...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PID2021-125597NB-I00
ESTUDIO ESTRUCTURAL DE LA UNION DE PROTEINAS DE BACTERIOFAGO...
121K€
Cerrado
ProbesPTRM
New chemical biology tools for proteome wide of profiling of...
209K€
Cerrado
BFU2016-78521-R
APLICACIONES BIOMEDICAS Y BIOTECNOLOGICAS DE MOTORES MOLECUL...
109K€
Cerrado
RYC-2011-07602
Exploring protein interactions and their modulation through...
184K€
Cerrado
BFU2011-25326
BIOLOGIA ESTRUCTURAL DE PROTEINAS DE LA PARED CELULAR BACTER...
288K€
Cerrado
SHIFTIDES
Shifting the oligomerization equilibrium of proteins a nove...
1M€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
In 2009 protein AMPylation, the reversible post-translational adenylation of target proteins with adenosine monophosphate (AMP), was first revealed as a novel mechanism for pathogenic bacteria to target and disrupt interactions of host GTPases with their cognate binding partners. Furthermore, there is growing evidence that AMPylation also operates as a general intracellular signaling mechanism in normal cell function. This novel post-translational modification is catalyzed by AMP transferases containing a so-called Fido motif that has been found across prokaryotes and eukaryotes, in over 2700 putative bacterial and mammalian proteins. Consequently, AMPylation is rapidly emerging as a fundamental mechanism to regulate protein-protein interactions and cell signaling in normal cells and in host-pathogen interactions, providing an opportunity for the discovery of new biology and targets for new antibiotics with novel mode of action. However, without robust tools to identify and manipulate both AMP transferases and their AMPylated protein substrates, our understanding of this complex signaling network will remain superficial.
This Fellowship project aims to develop and apply chemical probes and technologies that will enable for the first time high-throughput analysis and exploration of the complex biological networks involved in protein AMPylation. These chemical tools will be applied to mapping the changes in AMPylation that occur during bacterial infection in the host and the pathogen, with the ultimate objective of identifying and validating cellular mechanisms that can be targeted for future antimicrobial therapy.